Publicacións (121) Publicacións de JAVIER ZAMORA ROMERO

2024

  1. Corrigendum to “Propensity-Score Analysis Reveals that Sex is Not a Prognostic Factor for Mortality in Intensive Care Unit-Admitted Patients with Septic Bacteremia” [International Journal of Infectious Diseases, volume 110 (2021) pages 36-44, (S1201971221005907), (10.1016/j.ijid.2021.07.034)]

    International Journal of Infectious Diseases

  2. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors

    Journal of Hepatology

2023

  1. Metformin in the prevention of type 2 diabetes after gestational diabetes in postnatal women (OMAhA): A UK multicentre randomised, placebo-controlled, double-blind feasibility trial with nested qualitative study

    BMJ Open, Vol. 13, Núm. 11

2022

  1. Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists

    Clinical Gastroenterology and Hepatology, Vol. 20, Núm. 3, pp. e380-e397

  2. Left Ventricular Dysfunction Persists in the First Week after Re-Warming following Therapeutic Hypothermia for Hypoxic-Ischaemic Encephalopathy

    Neonatology, Vol. 119, Núm. 4, pp. 510-516

  3. Meta-DiSc 2.0: a web application for meta-analysis of diagnostic test accuracy data

    BMC Medical Research Methodology, Vol. 22, Núm. 1

  4. Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study

    BMJ open, Vol. 12, Núm. 3, pp. e050110

  5. Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights

    Trials, Vol. 23, Núm. 1

  6. Statistical Evaluation of Metaproteomics and 16S rRNA Amplicon Sequencing Techniques for Study of Gut Microbiota Establishment in Infants with Cystic Fibrosis

    Microbiology Spectrum, Vol. 10, Núm. 6

2021

  1. Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 10, pp. 2578-2585

  2. Follow-up care over 12months of patients with prostate cancer in Spain A multicenter prospective cohort study

    Medicine (United States), Vol. 100, Núm. 47

  3. Prognostic models for mortality after cardiac surgery in patients with infective endocarditis: a systematic review and aggregation of prediction models

    Clinical Microbiology and Infection, Vol. 27, Núm. 10, pp. 1422-1430

  4. Propensity-Score Analysis Reveals that Sex is Not a Prognostic Factor for Mortality in Intensive Care Unit-Admitted Patients with Septic Bacteremia

    International Journal of Infectious Diseases, Vol. 110, pp. 36-44

2020

  1. Effect of early cryoprecipitate transfusion versus standard care in women who develop severe postpartum haemorrhage (ACROBAT) in the UK: a protocol for a pilot cluster randomised trial

    BMJ open, Vol. 10, Núm. 6, pp. e036416

  2. Effectiveness and acceptability of metformin in preventing the onset of type 2 diabetes after gestational diabetes in postnatal women: A protocol for a randomised, placebo-controlled, double-blind feasibility trialOptimising health outcomes with Metformin to prevent diAbetes after pregnancy (OMAhA)

    BMJ Open, Vol. 10, Núm. 5

  3. Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial

    Trials, Vol. 21, Núm. 1

  4. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

2019

  1. Reply to Commentary on "Pulse Oximetry Screening for Critical Congenital Heart Defects"

    Neonatology

2018

  1. Estimated glomerular filtration rate is an early biomarker of cardiac surgery-associated acute kidney injury

    Nefrologia, Vol. 38, Núm. 6, pp. 596-605

  2. Individual patient data meta-analysis of randomized controlled trials of dual therapy with a boosted PI plus lamivudine for maintenance of virological suppression: GeSIDA study 9717

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 11, pp. 2927-2935